Management Forum Logo

Presented by
Management Forum

Process Validation with Qualification Training Course

A focused course on modern, lifecycle-based process validation and qualification. Learn how to design, qualify, and maintain manufacturing processes in a state of control using science- and risk-based approaches aligned with FDA, EU GMP Annex 15, MHRA, and WHO expectations - supporting compliant, efficient, right-first-time validation.

3-4 June 2026
+ 1-2 December 2026 »

from £1299

Need help?  Enrol/reserve

Course overview

Ensure your manufacturing processes are validated from end to end using modern, science-based practices that meet today’s global regulatory standards. In an era where regulators treat validation as a lifecycle activity rather than a one-time exercise, this course provides comprehensive training on how to design, qualify, and maintain processes in a state of control. 

Over two days, participants will learn to integrate process validation and equipment/facility qualification into a unified strategy, aligned with FDA’s 2011 Process Validation Guidance, EU GMP Annex 15, UK MHRA expectations, and WHO guidelines. The programme walks through each stage - from initial process design and scale-up (Stage 1), through Installation/Operational/Performance Qualification (IQ/OQ/PQ) and Process Performance Qualification (PPQ) (Stage 2), into ongoing Continued Process Verification (CPV) programs (Stage 3). 

Emphasis is placed on a risk- and science-based approach: leveraging tools like Quality by Design (QbD), Design of Experiments (DOE), and Process Analytical Technology (PAT) to build quality into the process, and using data analytics to monitor performance. Participants will also learn how to handle re-validation when changes or transfers occur, and how to document validation activities to satisfy inspectors. This course ensures you can validate processes efficiently and right-first time, supporting both compliance and operational excellence.

Browse our extensive selection of Life Sciences training courses for industry-leading insights into a range of topics. These include Medical Devices, IVDs, Biotech and Biopharma, Animal Health and Pharmaceutical training courses.

Benefits of attending

By attending this course, you will:

  • Implement Annex 15 / FDA lifecycle validation (Stage 1–3) beyond the obsolete “3-batch” model
  • Demonstrate sustained state of control using PPQ + CPV + PQR/APR integration
  • Align IQ/OQ/PQ with PPQ execution, meeting ISPE and PIC/S inspector expectations
  • Apply ICH Q8/Q9 risk-based validation, defending CQAs, CPPs, and acceptance criteria
  • Design inspection-ready PPQ protocols with statistical and scientific justification
  • Operationalise CPV and SPC trending, a growing FDA/MHRA inspection focus
  • Eliminate data integrity risk using ALCOA+ across validation records and systems
  • Validate digital tools correctly (spreadsheets, PAT, MES) per GAMP 5 and Annex 11
  • Adapt validation for modern manufacturing, including PAT, RTRT, and continuous processes
  • Control change without revalidation overkill, aligning Annex 15 with ICH Q12 principles

Who should attend

This course is ideal for professionals involved in pharmaceutical and biopharmaceutical development, manufacturing, engineering and quality who need to design, execute or assess process validation and qualification activities, including:

  • Validation Engineers and Specialists Scientists and development scientists
  • Pharmacists involved in product and process development
  • Quality Assurance professionals and quality managers
  • Quality control managers and senior analysts
  • Validation and Qualification Specialists/ Engineers
  • Technology transfer and scale-up managers
  • Risk management specialists
  • Lean and operational excellence specialists
  • Operations managers and production engineers
  • Late-stage product and process development staff
  • Regulatory Affairs Personnel (CMC)

Enrol/reserve

This course will cover:

Validation fundamentals and execution

Module 1: Regulatory overview of validation

  • EU GMP Annex 15 validation principles
  • FDA Process Validation lifecycle (Stage 1/2/3)
  • WHO TRS validation expectations (lifecycle approach)
  • ICH Q8, Q9, Q10, Q11, Q12 – Overview and Implications
  • FDA Vs Annex 15 

Module 2: Stage 1 - Process design & risk assessment (practical application)

  • QbD linkage: CQAs ↔ CPPs ↔ Control Strategy
  • ICH Q9 risk tools: FMEA / risk ranking / worst case
  • DOE-based parameter understanding (design space thinking)

Module 3: Stage 2.1 - qualification (IQ/OQ)

  • URS → DQ → IQ/OQ traceability
  • ISPE baseline approach (risk-based qualification philosophy)
  • HVAC & Utilities qualification fundamentals (critical systems)

Exercise 1: Building an equipment qualification strategy

Module 4: Stage 2.2 - PPQ / PQ execution

  • PPQ protocol essentials: acceptance criteria + rationale
  • Sampling plan: locations, frequency, worst case challenge
  • Statistical confidence: variability, capability, trending readiness

Module 5: Stage 3 - OPV / ongoing process verification

  • OPV plan: critical metrics, alert/action limits
  • SPC trending: control charts, shifts, drifts, signals
  • APR/PQR integration: trend to governance escalation

Exercise 2: SWOT analysis of validation strategy

Advanced Topics and Maintaining Control

Module 6: Validation documentation & data integrity (ALCOA+)

  • Validation Master Plan (VMP): Protocol writing: testable requirements + objective evidence
  • Part 11 / Annex 11 considerations (e-records / audit trails)
  • GAMP 5 alignment for validation systems support

Exercise 3: Designing an OPV system

Module 7: Advanced validation techniques

  • Continuous manufacturing validation concepts
  • PAT / RTRT readiness (sensor qualification + model validation)
  • Cleaning validation: MACO, worst case, residue strategy

Module 8: Maintaining the validated state & change control

  • Requalification vs revalidation triggers (risk-based decision)
  • Tech transfer interfaces: gap analysis + comparability evidence
  • Controlled change implementation

Module 9: Workshop - Validation Plan Build

  • Define CQAs/CPPs + control strategy map
  • PPQ design: batches, sampling, acceptance criteria
  • CPV dashboard: KPIs, alert/action limits, escalation path

Exercise 4 : Change scenario: assess revalidation requirements

Module 10: Inspection readiness & lessons learned

  • Inspector hot-spots: rationale, traceability, execution discipline
  • Common findings: weak acceptance criteria, poor deviation handling
  • Data integrity failure modes: gaps, backdating, missing raw data

Case Study: Building a sustainable ongoing verification programme

Enrol/reserve

Paul Palmer
Paul R Palmer Ltd

Paul R Palmer is a Director / Pharmaceutical Consultant and a practicing EU / UK Qualified Person. He has over 35 years experience in the pharmaceutical industry in the development, manufacture and supply of medicinal products and medical devices. 

Throughout his career, Paul has intentionally taken on all opportunities as they arose in order to develop a broad range of knowledge with an in-depth detailed understanding of manufacturing, storage, distribution, research, computerised systems, as well as the facilities and services to support each.

People and systems have always been a core focus, how to ensure best use, optimise and enhance efficiency. He has a level of curiosity rarely displayed in people taking on the qualified person role in pharmaceutical manufacturing. Culture, behaviour and psychology are all significant influences on the systems and processes we implement, but are often ignored.

Paul studied psychology as part of his MSc in 1993 and has always enjoyed observing the world around him with a curiosity that is rarely satisfied.

More details

NEW higher discounts for multiple bookings - bring your colleagues to make your training budget go further:

  • 30% off the 2nd delegate*
  • 40% off the 3rd delegate*
  • 50% off the 4th delegate*

Please contact us for pricing if you are interested in booking 5 or more delegates

3-4 June 2026

Live online

09:30-17:00 UK (London) (UTC+01)
10:30-18:00 Paris (UTC+02)
04:30-12:00 New York (UTC-04)
Course code 16897

  • GBP 1,299 1,499
  • EUR 1,819 2,099
  • USD 2,087 2,399

Until 29 Apr

View basket 

 
Not ready to book yet?

for 7 days, no obligation

1-2 December 2026

Live online

09:30-17:00 UK (London) (UTC+00)
10:30-18:00 Paris (UTC+01)
04:30-12:00 New York (UTC-05)
Course code 16898

  • GBP 1,299 1,499
  • EUR 1,819 2,099
  • USD 2,087 2,399

Until 27 Oct

View basket 

 
Not ready to book yet?

for 7 days, no obligation

* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price; and apply only when booking multiple delegates on the same date.

United Kingdom

  • Allergan Biologics
  • Associates of Cape Cod International Inc
  • AstraZeneca
  • AstraZeneca UK Ltd
  • Catalent Pharma Solutions
  • CooperVision
  • Crescent Pharma Ltd
  • Cyton Biosciences
  • DCA Design International
  • ECO Animal Health Group
  • Evotec
  • Fujifilm Diosynth Biotechnologies
  • Gerard's Quality Solutions
  • GW Pharmaceuticals
  • GW Pharmaceuticals PLC
  • Juniper Pharma Services Ltd
  • Kent Pharma UK Ltd
  • LabMinds Ltd
  • Life Technologies Ltd
  • MHRA
  • PCI Pharma services
  • Penn Pharmaceutical Services Limited
  • Piramal Pharma Solutions
  • Porton Biopharma LTD
  • Purolite Ltd
  • Reckitt Benckiser
  • STD Pharmaceutical Products Ltd
  • Surgical Innovations
  • Theramex
  • Thermo Fisher Scientific
  • Upperton Pharma Solutions
  • Wesley Coe (Cambridge) Limited

Switzerland

  • Actelion Pharmaceuticals Ltd
  • Arcondis
  • Bayer Consumer Care AG
  • F. Hoffmann-La Roche Ltd
  • Idorsia Pharmaceuticals Ltd.
  • Imtool Sarl
  • Janssen Cilag Farmaceutica
  • ObsEva SA
  • Sintetica SA

United States of America

  • Aldevron
  • Alkermes
  • Amway (UK) Ltd
  • Cepheid
  • Proveris Scientific Corporation
  • Renaissance Lakewood LLC

Netherlands

  • Biosynth B.V.
  • Kinesis Pharma
  • Merus NV
  • SPP
  • uniQure

Denmark

  • Alk-Abelló A/S
  • Alk-Abelló A/S
  • Emendo Research & Development
  • Fujifilm Diosynth Biotechnologies

Germany

  • CSL Behring GmbH
  • Intendis GmbH
  • Merck Healthcare KGaA
  • Sanofi-Aventis Deutschland GmbH

Ireland

  • Cilatus BioPharma Consulting
  • Cilatus Regulatory Services Ltd
  • Regeneron Pharmaceuticals
  • Univet Ltd

Italy

  • CHIESI FARMACEUTICI S P A
  • Chiesi Farmaceutici S.p.a.
  • REITHERA SRL

Israel

  • Medimop
  • Perrigo API

Austria

  • Sandoz GmbH

Belgium

  • Dentsply Implants NV

Finland

  • INION OY

France

  • Guerbet

Sweden

  • Cepheid

Enrol/reserve

Run Process Validation with Qualification Live online for your team

2 days

Typical duration

Pricing from:

  • GBP 1,000
  • Per attendee, based on 10 attendees
  • Course tailored to your requirements
  • At your choice of location, or online

 

We can customise this course to your requirements and deliver it on an in-house basis for any number of your staff or colleagues.

Contact our in-house training experts Aleksandra Beer and Yesim Nurko to discuss your requirements:

Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to one of our training experts to discuss how to:

Run this course conveniently and cost-effectively in-house for your staff and colleagues

Aleksandra Beer

Aleksandra
BEER

Training expert

Yesim Nurko

Yesim
NURKO

Training expert

Yesim Nurko

Harry
ALTAMONT

Training expert

+44 (0)20 7749 4749

inhouse@ipiacademy.com